UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549


FORM 8-K

CURRENT REPORT


PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934


Date of Report (Date of earliest event reported)

February 27, 2009

Bovie Medical Corporation
(Exact name of registrant as specified in its
charter)

Delaware
1-31885
11-2644611
(State or other jurisdiction
Of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
 
734 Walt Whitman Road, Melville, New York
11747
(Address of principal executive offices)
(Zip Code)

Registrant's telephone number, including area code
(631) 421-5452

N/A
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 

¨ Written communications pursuant to Rule 425 under the Securities Act 17 CFR 230.425)

¨ Soliciting material pursuant to Rule l4a-12 under the Exchange Act (17 CFR 240.l4a-12)

¨ Pre-commencement communications pursuant to Rule l4d- 2(b) under the Exchange Act (17 CFR 240. l4d- 2(b)

¨ Pre-commencement communications pursuant to Rule 13 e-4( c) under the Exchange Act (17 CFR 240.13 e-4( c)

 
 
 
 
ITEM: 5.02
Departure of Directors or Certain Officers, Election of Directors, Appointment of Certain Officers, Compensatory Arrangements of Certain Officers.

(a)(i) Effective February 27, 2009, Randy Rossi resigned as director of registrant due to new employment which will prohibit his continued services as a director.  Mr. Rossi has acknowledged that there are no disagreements with registrant concerning operations, policies or practices.


Signatures


Pursuant to the requirements of Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Bovie Medical Corporation


Date:  March 2, 2009
Bovie Medical Corp
(Registrant)
 
By:
/S/   Andrew Makrides
  
 
Andrew Makrides, President and CEO